rs752869904

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_007346.4(OGFR):​c.965A>C​(p.Glu322Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000703 in 1,423,380 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E322K) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000070 ( 0 hom. )

Consequence

OGFR
NM_007346.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.01

Publications

0 publications found
Variant links:
Genes affected
OGFR (HGNC:15768): (opioid growth factor receptor) The protein encoded by this gene is a receptor for opioid growth factor (OGF), also known as [Met(5)]-enkephalin. OGF is a negative regulator of cell proliferation and tissue organization in a variety of processes. The encoded unbound receptor for OGF has been localized to the outer nuclear envelope, where it binds OGF and is translocated into the nucleus. The coding sequence of this gene contains a polymorphic region of 60 nt tandem imperfect repeat units. Several transcripts containing between zero and eight repeat units have been reported. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0632067).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OGFRNM_007346.4 linkc.965A>C p.Glu322Ala missense_variant Exon 7 of 7 ENST00000290291.10 NP_031372.2 Q9NZT2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OGFRENST00000290291.10 linkc.965A>C p.Glu322Ala missense_variant Exon 7 of 7 1 NM_007346.4 ENSP00000290291.6 Q9NZT2-1
OGFRENST00000370461.5 linkc.809A>C p.Glu270Ala missense_variant Exon 5 of 5 2 ENSP00000359491.1 A0A0A0MRN5

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000112
AC:
2
AN:
179340
AF XY:
0.0000102
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000271
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000703
AC:
10
AN:
1423380
Hom.:
0
Cov.:
71
AF XY:
0.00000852
AC XY:
6
AN XY:
704610
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32684
American (AMR)
AF:
0.00
AC:
0
AN:
38498
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25496
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37826
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81862
European-Finnish (FIN)
AF:
0.0000406
AC:
2
AN:
49290
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5700
European-Non Finnish (NFE)
AF:
0.00000640
AC:
7
AN:
1093016
Other (OTH)
AF:
0.0000169
AC:
1
AN:
59008
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.540
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.0000594
AC:
7

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 11, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.965A>C (p.E322A) alteration is located in exon 7 (coding exon 7) of the OGFR gene. This alteration results from a A to C substitution at nucleotide position 965, causing the glutamic acid (E) at amino acid position 322 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
8.3
DANN
Benign
0.73
DEOGEN2
Benign
0.012
T;.
Eigen
Benign
-0.90
Eigen_PC
Benign
-0.92
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.55
T;T
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.063
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.6
L;.
PhyloP100
3.0
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.8
N;N
REVEL
Benign
0.030
Sift
Uncertain
0.010
D;D
Sift4G
Benign
0.64
T;T
Polyphen
0.0080
B;.
Vest4
0.065
MutPred
0.11
Loss of phosphorylation at S324 (P = 0.1805);.;
MVP
0.20
MPC
0.31
ClinPred
0.080
T
GERP RS
2.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.062
gMVP
0.19
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs752869904; hg19: chr20-61443932; API